Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 9/20 | 0.53 |
| ▸ | FAP | Q12884 | 2/20 | 0.53 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.53 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.53 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.53 |
| ▸ | AKT1 | P31749 | 3/20 | 0.48 |
| ▸ | AKT2 | P31751 | 1/20 | 0.48 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 6/20 | 0.48 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23211355 | 0.86 | S1PR1 (0.51) | DPP4FAPDPP8DPP9DPP7 | |
| SCHEMBL21410996 | 0.86 | S1PR1 (0.51) | DPP4FAPDPP8DPP9DPP7 | |
| SCHEMBL25541767 | 0.85 | DPP4 (0.56) | DPP4FAPDPP8DPP9DPP7 | |
| SCHEMBL23211432 | 0.85 | DPP4 (0.50) | DPP4FAPDPP8DPP9DPP7 | |
| SCHEMBL23211434 | 0.85 | DPP4 (0.50) | DPP4FAPDPP8DPP9DPP7 | |
| SCHEMBL23211381 | 0.83 | DPP4 (0.61) | DPP4FAPDPP8DPP9DPP7 | |
| SCHEMBL21411220 | 0.83 | DPP4 (0.61) | DPP4FAPDPP8DPP9DPP7 | |
| SCHEMBL29910014 | 0.82 | ALDH1A1 (0.50) | DPP4FAPDPP8DPP9DPP7 | |
| SCHEMBL28499545 | 0.82 | ALDH1A1 (0.50) | DPP4FAPDPP8DPP9DPP7 | |
| SCHEMBL23211486 | 0.82 | DPP4 (0.57) | DPP4FAPDPP8DPP9DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020150385-A1 | ANTIMICROBIAL COMPOUNDS AND METHODS | CURZA GLOBAL, LLC (US) | 2020-07-23 | — | — | WO | disclosed |